Clinical Trial Update: Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial update evaluating amantadine as an adjunctive therapy to antipsychotics in schizophrenia; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• amantadine (amantadine)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Schizophrenia | Phase 3 | Status: UNKNOWN